Venous Thrombosis in Wegener Granulomatosis. Ann Intern Med. 2005;142:I-54. doi: 10.7326/0003-4819-142-8-200504190-00004
Download citation file:
Published: Ann Intern Med. 2005;142(8):I-54.
Wegener granulomatosis is an uncommon disease in which the blood vessels are inflamed (vasculitis). The inflammation of the vessels limits blood flow to body organs. Wegener granulomatosis mainly affects the respiratory tract and the kidneys. Symptoms are often vague and may include cold symptoms, such as runny nose, sinus pain, bloody discharge from the nose, cough, shortness of breath, joint pains, rashes, weakness, or tiredness. Some patients with Wegener granulomatosis also get blood clots in their veins (venous thromboembolism or VTE). These clots can cause serious and even fatal complications. Researchers do not know how often VTEs occur in patients with Wegener granulomatosis.
To find out how often patients with Wegener granulomatosis have VTEs.
180 adults with Wegener granulomatosis who were enrolled in a multicenter drug treatment trial; 167 of them had no history of VTEs.
The researchers followed the patients every 3 months from June 2000 through December 2002. They assessed symptoms and signs of Wegener granulomatosis and adverse events, such as VTEs. They used any of several tests to confirm suspected VTEs, including lung scanning, ultrasonography, and dye tests of the vessels in the legs or lungs. The researchers summed the amount of time that patients were followed by using a measure called person-years. With this measure, 1 person followed for 2 years contributes 2 person-years, while 10 people followed for 6 months contribute 5 person-years. The researchers then estimated the incidence of VTEs per person-year of follow-up.
16 VTEs occurred in patients with no history of VTEs. The incidence of VTEs was 7 per 100 person-years.
The researchers tested for VTE only if patients had symptoms or physical signs that suggested VTE. Some VTEs may have been missed.
Patients with Wegener granulomatosis have a high incidence of VTE. Their incidence of 7 VTEs per 100 person-years is much higher than that in the general population (about 0.3 per 100 person-years) and is also higher than that in patients with systemic lupus erythematosus (about 1 per 100 person-years).
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Nephrology, Pulmonary/Critical Care, Rheumatology, Venous Thromboembolism, Autoimmune Kidney Disease.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only